zalcitabine has been researched along with phosphatidylcholines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, HW; Spence, MW | 1 |
| Baes, MI; Balzarini, J; De Groote, K; Declercq, PE; Naesens, L | 1 |
| Bergeron, MG; Désormeaux, A; Gourde, P; Makabi-Panzu, B | 1 |
3 other study(ies) available for zalcitabine and phosphatidylcholines
| Article | Year |
|---|---|
Dideoxycytidine, an anti-HIV drug, selectively inhibits growth but not phosphatidylcholine metabolism in neuroblastoma and glioma cells.
Topics: Cell Division; Dideoxynucleosides; Glioma; Humans; Neuroblastoma; Phosphatidylcholines; Tumor Cells, Cultured; Zalcitabine | 1989 |
Effects of 2',3'-dideoxycytidine and 2',3'-dideoxycytidine 5'-triphosphate on phospholipid metabolism in permeabilized rat hepatocytes.
Topics: Animals; Cell Membrane Permeability; Cells, Cultured; Deoxycytosine Nucleotides; Dideoxynucleotides; Liver; Male; Phosphatidylcholines; Phosphatidylethanolamines; Rats; Rats, Wistar; Zalcitabine | 1997 |
Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-HIV Agents; Cell Compartmentation; Cell Line; Cholesterol; Culture Media, Serum-Free; Dimyristoylphosphatidylcholine; Drug Carriers; Drug Compounding; Drug Stability; Intracellular Fluid; Lipids; Liposomes; Macrophages; Mice; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Zalcitabine | 1998 |